These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37022983)

  • 41. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study.
    Scott ES; Januszewski AS; O'Connell R; Fulcher G; Scott R; Kesaniemi A; Wu L; Colagiuri S; Keech A; Jenkins AJ
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32766757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased glycemic variability in patients with elevated preoperative HbA1C predicts adverse outcomes following coronary artery bypass grafting surgery.
    Subramaniam B; Lerner A; Novack V; Khabbaz K; Paryente-Wiesmann M; Hess P; Talmor D
    Anesth Analg; 2014 Feb; 118(2):277-287. PubMed ID: 24445629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Association Between Preoperative Hemoglobin A1C and Postoperative Glycemic Variability on 30-Day Major Adverse Outcomes Following Isolated Cardiac Valvular Surgery.
    Bardia A; Khabbaz K; Mueller A; Mathur P; Novack V; Talmor D; Subramaniam B
    Anesth Analg; 2017 Jan; 124(1):16-22. PubMed ID: 27861432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycemic Control Status After Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients With Type 2 Diabetes Mellitus.
    Hwang JK; Lee SH; Song YB; Ahn J; Carriere K; Jang MJ; Park TK; Choi SH; Yang JH; Choi JH; Lee SH; Gwon HC; Hahn JY
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28373177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Longitudinal Values of Glycated Hemoglobin With Cardiovascular Events in Patients With Type 2 Diabetes and Multivessel Coronary Artery Disease.
    Rezende PC; Hlatky MA; Hueb W; Garcia RMR; da Silva Selistre L; Lima EG; Garzillo CL; Scudeler TL; Boros GAB; Ribas FF; Serrano CV; Ramires JAF; Kalil Filho R
    JAMA Netw Open; 2020 Jan; 3(1):e1919666. PubMed ID: 31968117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility of hemoglobin A1c in predicting diabetes risk.
    Edelman D; Olsen MK; Dudley TK; Harris AC; Oddone EZ
    J Gen Intern Med; 2004 Dec; 19(12):1175-80. PubMed ID: 15610327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of diabetes and glycaemic control on peripheral artery disease in Japanese patients with end-stage renal disease: long-term follow-up study from the beginning of haemodialysis.
    Ishii H; Kumada Y; Takahashi H; Toriyama T; Aoyama T; Tanaka M; Yoshikawa D; Hayashi M; Kasuga H; Yasuda Y; Maruyama S; Matsubara T; Matsuo S; Murohara T
    Diabetologia; 2012 May; 55(5):1304-9. PubMed ID: 22297583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Associations between attainment of incentivized primary care indicators and incident lower limb amputation among those with type 2 diabetes: a population-based historical cohort study.
    Gunn LH; Vamos EP; Majeed A; Normahani P; Jaffer U; Molina G; Valabhji J; McKay AJ
    BMJ Open Diabetes Res Care; 2021 Apr; 9(1):. PubMed ID: 33903115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes.
    Yang CP; Lin CC; Li CI; Liu CS; Lin CH; Hwang KL; Yang SY; Li TC
    Cardiovasc Diabetol; 2020 Jan; 19(1):4. PubMed ID: 31910828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study.
    Mohammedi K; Woodward M; Hirakawa Y; Zoungas S; Colagiuri S; Hamet P; Harrap S; Poulter N; Matthews DR; Marre M; Chalmers J;
    Cardiovasc Diabetol; 2016 Sep; 15(1):129. PubMed ID: 27590190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus.
    Long C; Tang Y; Huang J; Liu S; Xing Z
    Front Endocrinol (Lausanne); 2022; 13():975468. PubMed ID: 36034445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Population-Based Analysis of Diabetes-Related Care Measures, Foot Complications, and Amputation During the COVID-19 Pandemic in Ontario, Canada.
    de Mestral C; Gomez D; Wilton AS; Lee DS; Albalawi Z; Austin PC; Jacob-Brassard J; Urbach DR; Al-Omran M; Baxter NN
    JAMA Netw Open; 2022 Jan; 5(1):e2142354. PubMed ID: 34985514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Prenatal and Perinatal Exposures to Particulate Matter With Changes in Hemoglobin A1c Levels in Children Aged 4 to 6 Years.
    Moody EC; Cantoral A; Tamayo-Ortiz M; Pizano-Zárate ML; Schnaas L; Kloog I; Oken E; Coull B; Baccarelli A; Téllez-Rojo MM; Wright RO; Just AC
    JAMA Netw Open; 2019 Dec; 2(12):e1917643. PubMed ID: 31851346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes.
    Lu J; Wang C; Cai J; Shen Y; Chen L; Zhang L; Lu W; Zhu W; Hu G; Xia T; Zhou J
    J Clin Endocrinol Metab; 2021 Oct; 106(11):3160-3167. PubMed ID: 34279663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes.
    Hu J; Hsu H; Yuan X; Lou K; Hsue C; Miller JD; Lu J; Lee Y; Lou Q
    J Endocrinol Invest; 2021 Jun; 44(6):1229-1236. PubMed ID: 32897535
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HbA1c and lower-extremity amputation risk in low-income patients with diabetes.
    Zhao W; Katzmarzyk PT; Horswell R; Wang Y; Johnson J; Heymsfield SB; Cefalu WT; Ryan DH; Hu G
    Diabetes Care; 2013 Nov; 36(11):3591-8. PubMed ID: 24062322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ethnicity and risk of lower limb amputation in people with Type 2 diabetes: a prospective cohort study.
    Robinson TE; Kenealy T; Garrett M; Bramley D; Drury PL; Elley CR
    Diabet Med; 2016 Jan; 33(1):55-61. PubMed ID: 25982171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose.
    Lin CC; Chen CC; Chen FN; Li CI; Liu CS; Lin WY; Yang SY; Lee CC; Li TC
    Am J Med; 2013 Nov; 126(11):1017.e1-10. PubMed ID: 23993260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of Intensive Glycemic Control on Clinical Outcomes Among Patients With Type 2 Diabetes With Different Levels of Cardiovascular Risk and Hemoglobin A
    Tian J; Ohkuma T; Cooper M; Harrap S; Mancia G; Poulter N; Wang JG; Zoungas S; Woodward M; Chalmers J
    Diabetes Care; 2020 Jun; 43(6):1293-1299. PubMed ID: 32193249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving outcomes for diabetic patients undergoing revascularization for critical limb ischemia: does the quality of outpatient diabetic care matter?
    Brooke BS; Kraiss LW; Stone DH; Nolan B; De Martino RR; Reiber GE; Goodman DC; Cronenwett JL; Goodney PP
    Ann Vasc Surg; 2014 Oct; 28(7):1719-28. PubMed ID: 24911812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.